ARS Pharmaceuticals
IPOARS Pharma – Developing Biotechnology
Public · San Diego, United States · Founded 2015 · $75.0M raised
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- ars-pharma.com
- Total Funding
- $75.0M
- Last Round
- $55.0M Series DAug 2021
- Rounds
- 2
- Type
- Public
About
Develops and commercializes neffy, an FDA-approved needle-free epinephrine nasal spray for treating severe allergic reactions and anaphylaxis.
Summary
ARS Pharmaceuticals is a Healthcare company based in San Diego, United States, founded in 2015. It has raised $75.0M in total across 2 rounds, most recently a $55.0M Series D round in Aug 2021. Investors include RA Capital Management, Deerfield Management and SR One.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...